Based on the molecular mechanism discovered by us in this study, although glioblastomas have an unfavorable soft environment for YAP/TAZ activation, they may ensure plasticity by exploiting the surrounding noradrenaline to activate PKC and maintain YAP/TAZ activity. This evidence concerns the gene PRRT2 and glioblastoma.